These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2226990)

  • 1. Precorneal residence times of sodium hyaluronate solutions studied by quantitative gamma scintigraphy.
    Snibson GR; Greaves JL; Soper ND; Prydal JI; Wilson CG; Bron AJ
    Eye (Lond); 1990; 4 ( Pt 4)():594-602. PubMed ID: 2226990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular surface residence times of artificial tear solutions.
    Snibson GR; Greaves JL; Soper ND; Tiffany JM; Wilson CG; Bron AJ
    Cornea; 1992 Jul; 11(4):288-93. PubMed ID: 1424647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the precorneal residence of an artificial tear preparation in patients with keratoconjunctivitis sicca and normal volunteer subjects using gamma scintigraphy.
    Greaves JL; Wilson CG; Galloway NR; Birmingham AT; Olejnik O
    Acta Ophthalmol (Copenh); 1991 Aug; 69(4):432-6. PubMed ID: 1750310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium hyaluronate eyedrops enhance tear film stability.
    Hamano T; Horimoto K; Lee M; Komemushi S
    Jpn J Ophthalmol; 1996; 40(1):62-5. PubMed ID: 8739501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies of various hyaluronic acids produced by microbial fermentation for potential topical ophthalmic applications.
    Guillaumie F; Furrer P; Felt-Baeyens O; Fuhlendorff BL; Nymand S; Westh P; Gurny R; Schwach-Abdellaoui K
    J Biomed Mater Res A; 2010 Mar; 92(4):1421-30. PubMed ID: 19358259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of artificial tears in the management of evaporative dry eye.
    McCann LC; Tomlinson A; Pearce EI; Papa V
    Cornea; 2012 Jan; 31(1):1-5. PubMed ID: 21968605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance profile of sodium hyaluronate in patients with lipid tear deficiency: randomised, double-blind, controlled, exploratory study.
    Prabhasawat P; Tesavibul N; Kasetsuwan N
    Br J Ophthalmol; 2007 Jan; 91(1):47-50. PubMed ID: 16973668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a new tear substitute containing glycerol and hyaluronate on keratoconjunctivitis sicca.
    Solomon A; Merin S
    J Ocul Pharmacol Ther; 1998 Dec; 14(6):497-504. PubMed ID: 9867333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the effect of the sodium hyaluronate ophthalmic solution on tear film stability--non-contact specular microscopic evaluation].
    Hamano T; Horimoto K; Lee M; Komemushi S
    Nippon Ganka Gakkai Zasshi; 1993 Aug; 97(8):928-32. PubMed ID: 8368180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of tear substitutes and their immediate effect on the precorneal tear film.
    Avisar R; Creter D; Levinsky H; Savir H
    Isr J Med Sci; 1997 Mar; 33(3):194-7. PubMed ID: 9313790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viscosity-dependent fluid dynamics of eyedrops on the ocular surface.
    Shimmura S; Goto E; Shimazaki J; Tsubota K
    Am J Ophthalmol; 1998 Mar; 125(3):386-8. PubMed ID: 9512158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precorneal residence time in humans of sodium hyaluronate as measured by gamma scintigraphy.
    Gurny R; Ryser JE; Tabatabay C; Martenet M; Edman P; Camber O
    Graefes Arch Clin Exp Ophthalmol; 1990; 228(6):510-2. PubMed ID: 2176168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Color discrimination in patients with keratoconjunctivitis sicca before and after artificial tear application.
    Rieger G
    Wien Klin Wochenschr; 1998 Apr; 110(8):296-7. PubMed ID: 9615962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops.
    Hwang HS; Sung YM; Lee WS; Kim EC
    Cornea; 2014 Sep; 33(9):935-41. PubMed ID: 25055152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium hyaluronate in the treatment of keratoconjunctivitis sicca. A double masked clinical trial.
    Sand BB; Marner K; Norn MS
    Acta Ophthalmol (Copenh); 1989 Apr; 67(2):181-3. PubMed ID: 2658462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sodium hyaluronate ophthalmic solution on peripheral staining of rigid contact lens wearers.
    Itoi M; Kim O; Kimura T; Kanai A; Momose T; Kanki K; Yamaguchi T; Ueno Y; Kurokawa M; Komemushi S
    CLAO J; 1995 Oct; 21(4):261-4. PubMed ID: 8565197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical use of sodium hyaluronate eyedrops as a substitute for tears].
    He Z; Han S; Zhen Z; Ding X; Liang S
    Yan Ke Xue Bao; 1990 Dec; 6(3-4):111-2. PubMed ID: 2289573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with diquafosol tetrasodium and sodium hyaluronate in patients with dry eye after laser in situ keratomileusis.
    Toda I; Ide T; Fukumoto T; Ichihashi Y; Tsubota K
    Am J Ophthalmol; 2014 Mar; 157(3):616-22.e1. PubMed ID: 24528935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of sodium hyaluronate as viscous vehicle for eye drops.
    Ludwig A; Van Ooteghem M
    J Pharm Belg; 1989; 44(6):391-7. PubMed ID: 2632760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients.
    Lee HK; Ryu IH; Seo KY; Hong S; Kim HC; Kim EK
    Ophthalmology; 2006 Feb; 113(2):198-205. PubMed ID: 16360211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.